Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain

Authors: Carlos Fernández-Benítez, Patricia Mejuto-López, Luis Otero-Guerra, Mario Juan Margolles-Martins, Pilar Suárez-Leiva, Fernando Vazquez, Chlamydial Primary Care Group

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

There are no accurate data regarding the real prevalence of Chlamydia trachomatis infection in Spain. Our aim was to determine the prevalence of C. trachomatis infections and the risk factors for acquiring them among 1,048 young (15–24 years old) inhabitants of Laviana.

Methods

The study was completed in the period between 1st November 2010 and 31st December 2011. We conducted a capture strategy in the whole population, instead of only in a sample group, with a capture conducted in schools, in the local health centre, by post and by phone as a last resort. The design was based on the model used by Shafer to increase screening rates. C. trachomatis was identified by RT-PCR in urine samples.

Results

A total of 487 sexually active people underwent the test, which implies a response rate of 59.8% of the sexually active people (target population). The prevalence was 4.1% (CI 95%: 3.1-5.8): women: 4% ( CI 95%; 2.8-6.4) and men: 4.3% (CI 95%: 2.9-7.2). The circulating genotype was the E genotype. There was an increase in the risk of C. trachomatis infection when barrier contraceptives were not routinely used OR: 4.76 (CI 95%:1.30-17.36) p<0.05.

Conclusions

In our study the prevalence in women resembles those found in other countries in Europe and the prevalence in men is similar to that in women. Screening for C. trachomatis infection in women would be cost-effective in Spain given the prevalence of C. trachomatis measured by this study. The use of a condom is the best preventative measure for avoiding STIs in sexually active people.
Appendix
Available only for authorised users
Literature
2.
go back to reference Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB: Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010, 201 (Suppl 2): S134-S155.CrossRefPubMed Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB: Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis. 2010, 201 (Suppl 2): S134-S155.CrossRefPubMed
3.
go back to reference Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999, 7: 3-17.CrossRef Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999, 7: 3-17.CrossRef
4.
go back to reference Preventive Services US, Task Force: Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007, 147: 128-134.CrossRef Preventive Services US, Task Force: Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007, 147: 128-134.CrossRef
5.
go back to reference Cacho J, Sanz F, Blanco M: Silent disease caused by Chlamydia trachomatis: the urgent need for it to be detected and treated in women. Enferm Infecc Microbiol Clin. 2001, 19: 419-421. 10.1016/S0213-005X(01)72684-5.CrossRefPubMed Cacho J, Sanz F, Blanco M: Silent disease caused by Chlamydia trachomatis: the urgent need for it to be detected and treated in women. Enferm Infecc Microbiol Clin. 2001, 19: 419-421. 10.1016/S0213-005X(01)72684-5.CrossRefPubMed
6.
go back to reference Shafer MA, Tebb KP, Pantell RH, Wibbelsman CJ, Neuhaus JM, Tipton AC, Kunin SB, Ko TH, Schweppe DM, Bergman DA: Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA. 2002, 288: 2846-2852. 10.1001/jama.288.22.2846.CrossRefPubMed Shafer MA, Tebb KP, Pantell RH, Wibbelsman CJ, Neuhaus JM, Tipton AC, Kunin SB, Ko TH, Schweppe DM, Bergman DA: Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA. 2002, 288: 2846-2852. 10.1001/jama.288.22.2846.CrossRefPubMed
7.
go back to reference Lysén M, Osterlund A, Rubin CJ, Persson T, Persson I, Herrmann B: Characterization of OmpA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish county. J Clin Microbiol. 2004, 42: 1641-1647. 10.1128/JCM.42.4.1641-1647.2004.CrossRefPubMedPubMedCentral Lysén M, Osterlund A, Rubin CJ, Persson T, Persson I, Herrmann B: Characterization of OmpA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish county. J Clin Microbiol. 2004, 42: 1641-1647. 10.1128/JCM.42.4.1641-1647.2004.CrossRefPubMedPubMedCentral
8.
go back to reference Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B: Cost effectiveness for screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002, 78: 406-412. 10.1136/sti.78.6.406.CrossRefPubMedPubMedCentral Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B: Cost effectiveness for screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect. 2002, 78: 406-412. 10.1136/sti.78.6.406.CrossRefPubMedPubMedCentral
9.
go back to reference Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, Coll C, Saludes V, Casabona J: Prevalence and determining factors of acquiring C. trachomatis infection among adolescents and young adults in Catalonia. Enferm Infecc Microbiol Clin. 2011, 29: 96-101. 10.1016/j.eimc.2010.08.011.CrossRefPubMed Corbeto EL, Lugo R, Martró E, Falguera G, Ros R, Avecilla A, Coll C, Saludes V, Casabona J: Prevalence and determining factors of acquiring C. trachomatis infection among adolescents and young adults in Catalonia. Enferm Infecc Microbiol Clin. 2011, 29: 96-101. 10.1016/j.eimc.2010.08.011.CrossRefPubMed
10.
go back to reference Nogales MC, Castro C, Ramírez M, Pueyo I, Pérez L, Jarana R, Martín E: Diagnosis of Chlamydia trachomatis infection in a clinic for sexually transmitted disease: evaluation of cervical, urethral and rectal swab samples by polymerase chain reaction. Enferm Infecc Microbiol Clin. 2007, 25: 11-15. 10.1157/13096747.CrossRefPubMed Nogales MC, Castro C, Ramírez M, Pueyo I, Pérez L, Jarana R, Martín E: Diagnosis of Chlamydia trachomatis infection in a clinic for sexually transmitted disease: evaluation of cervical, urethral and rectal swab samples by polymerase chain reaction. Enferm Infecc Microbiol Clin. 2007, 25: 11-15. 10.1157/13096747.CrossRefPubMed
11.
go back to reference Folch C, Esteve A, Sanclemente C, Martró E, Lugo R, Molinos S, Gonzalez V, Ausina V, Casabona J: Prevalence of human immunodeficiency virus, Chlamydia trachomatis, and Neisseria gonorrhoeae and risk factors for sexually transmitted infections among immigrant female sex workers in Catalonia, Spain. Sex Transm Dis. 2008, 35: 178-183. 10.1097/OLQ.0b013e31815a848d.CrossRefPubMed Folch C, Esteve A, Sanclemente C, Martró E, Lugo R, Molinos S, Gonzalez V, Ausina V, Casabona J: Prevalence of human immunodeficiency virus, Chlamydia trachomatis, and Neisseria gonorrhoeae and risk factors for sexually transmitted infections among immigrant female sex workers in Catalonia, Spain. Sex Transm Dis. 2008, 35: 178-183. 10.1097/OLQ.0b013e31815a848d.CrossRefPubMed
12.
go back to reference Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J, CSF group: Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infec. 2010, 86: 263-270. 10.1136/sti.2009.038752.CrossRef Goulet V, de Barbeyrac B, Raherison S, Prudhomme M, Semaille C, Warszawski J, CSF group: Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France. Sex Transm Infec. 2010, 86: 263-270. 10.1136/sti.2009.038752.CrossRef
13.
go back to reference Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G, Field J, Erens B: Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001, 358: 1851-1854. 10.1016/S0140-6736(01)06886-6.CrossRefPubMed Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, Mercer CH, Carder C, Copas AJ, Nanchahal K, Macdowall W, Ridgway G, Field J, Erens B: Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet. 2001, 358: 1851-1854. 10.1016/S0140-6736(01)06886-6.CrossRefPubMed
14.
go back to reference Klavs I, Rodriguez LC, Wellings K, Kese D, Hayes R: Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect. 2004, 80: 121-123. 10.1136/sti.2003.005900.CrossRefPubMedPubMedCentral Klavs I, Rodriguez LC, Wellings K, Kese D, Hayes R: Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control. Sex Transm Infect. 2004, 80: 121-123. 10.1136/sti.2003.005900.CrossRefPubMedPubMedCentral
15.
go back to reference Centers for Disease Control and Prevention: CDC Grand Rounds: Chlamydia Prevention: challenges and strategies for reducing disease burden and sequelae. MMWR. 2011, 60: 370-373. Centers for Disease Control and Prevention: CDC Grand Rounds: Chlamydia Prevention: challenges and strategies for reducing disease burden and sequelae. MMWR. 2011, 60: 370-373.
16.
go back to reference Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR: Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004, 291: 2229-2236. 10.1001/jama.291.18.2229.CrossRefPubMed Miller WC, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR: Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. 2004, 291: 2229-2236. 10.1001/jama.291.18.2229.CrossRefPubMed
17.
go back to reference Kretzschmar M, Satterwhite C, Leichliter J, Berman S: Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study. Sex Transm Dis. 2012, 39: 325-331. 10.1097/OLQ.0b013e31824e52c2.CrossRefPubMed Kretzschmar M, Satterwhite C, Leichliter J, Berman S: Effects of screening and partner notification on Chlamydia positivity in the United States: a modeling study. Sex Transm Dis. 2012, 39: 325-331. 10.1097/OLQ.0b013e31824e52c2.CrossRefPubMed
18.
go back to reference Johnson TP, Wislar JS: Response rates and nonresponse errors in surveys. JAMA. 2012, 307: 1805-1806. 10.1001/jama.2012.3532.CrossRefPubMed Johnson TP, Wislar JS: Response rates and nonresponse errors in surveys. JAMA. 2012, 307: 1805-1806. 10.1001/jama.2012.3532.CrossRefPubMed
Metadata
Title
Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain
Authors
Carlos Fernández-Benítez
Patricia Mejuto-López
Luis Otero-Guerra
Mario Juan Margolles-Martins
Pilar Suárez-Leiva
Fernando Vazquez
Chlamydial Primary Care Group
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-388

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgement 2012

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.